Literature DB >> 3797390

Effect of population screening for cancer of the uterine cervix in Nijmegen, The Netherlands.

Y van der Graaf, P J Klinkhamer, G P Vooijs.   

Abstract

Since the introduction of a population screening program for cervical cancer in 1976, more than 85% of the female population between the ages of 35 and 54 years in the region of the city of Nijmegen, The Netherlands, has been screened. At first screening, severe epithelial abnormalities were diagnosed in 4.4 per 1,000 women, at second screening, in 1.5 per 1,000; and at third screening, in 1.0 per 1,000. The population screening program led to a marked increase in the detected number of carcinomata in situ. The number of cases of squamous cell cancer diagnosed in the first screening period did not increase. Once the population was screened, the detection rate of invasive squamous cell cancer in the group of women ages 35 through 54 decreased from 18.6 per 10(5) during the period prior to the screening to 9.0 per 10(5) after the first screening and 3.3 per 10(5) after the second screening. For the women above age 54, the incidence of invasive cancer was reduced by 58% after the second screening. The number of invasive cancers diagnosed in women under age 35 remained relatively small in spite of the large number of cases of carcinoma in situ.

Entities:  

Mesh:

Year:  1986        PMID: 3797390     DOI: 10.1016/0091-7435(86)90063-0

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  7 in total

1.  False negative rate in cervical cytology.

Authors:  Y van der Graaf; G P Vooijs
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

2.  Preliminary results of a general practice based call system for cervical cancer screening in The Netherlands.

Authors:  B T Palm; A C Kant; W J van den Bosch; G P Vooijs; C van Weel
Journal:  Br J Gen Pract       Date:  1993-12       Impact factor: 5.386

3.  Patterns of breast and cervical cancer screening at three public health centers in an inner-city urban area.

Authors:  S Whitman; D Ansell; L Lacey; E H Chen; N Ebie; J Dell; C W Phillips
Journal:  Am J Public Health       Date:  1991-12       Impact factor: 9.308

4.  Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases.

Authors:  M Gök; L Rozendaal; J Berkhof; O Visser; C J L M Meijer; F J van Kemenade
Journal:  Br J Cancer       Date:  2011-01-25       Impact factor: 7.640

5.  Teenage cervical screening in a high risk American population.

Authors:  Songlin Zhang; Jaiyeola Thomas; Joel Thibodeaux; Ami Bhalodia; Fleurette Abreo
Journal:  Cytojournal       Date:  2011-05-31       Impact factor: 2.091

6.  Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls.

Authors:  S Yogeshkumar; Jean Anderson; Enriquito Lu; Edward Kenyi; Margaret Mensa; Katrina Thaler; Ramalingappa Antartani; Kasturi Donimath; Basavaraj Patil; Santosh Chikaraddi; Shailaja Bidri; Aruna Biradar; Muttappa R Gudadinni; Laxmikant Lokare; Gayane Yenokyan; Mrutyunjaya B Bellad; Shivaprasad S Goudar; Richard Derman; Amit Revankar; Hema Patil; Ramadevi Wani; Ranjit Kangle; Ramesh Y Chavan; Mahantesh B Nagmoti; Yogendra M Kabadi; Purushotham Reddy; Sunita Vernekar; Surekha Hipparagi; Vijayalaxmi Patil; Anita Dalal
Journal:  Trials       Date:  2021-12-13       Impact factor: 2.279

7.  A case-control study of the effectiveness of cervical cancer screening in Osaka, Japan.

Authors:  T Sobue; T Suzuki; S Hashimoto; N Yokoi; I Fujimoto
Journal:  Jpn J Cancer Res       Date:  1988-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.